Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AbbVie seeks FDA approval for non-small cell lung cancer treatment
The company filed a BLA seeking accelerated approval for Teliso-V, targeting non-small cell lung cancer with c-Met overexpression. Credit: © AbbVie Inc. All rights reserved.
The company filed a BLA seeking accelerated approval for Teliso-V, targeting non-small cell lung cancer with c-Met overexpression. Credit: © AbbVie Inc. All rights reserved.